SUPERNUS PHARMACEUTICALS, INC. Unrealized Gain (Loss) on Derivatives
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Unrealized Gain (Loss) on Derivatives of -$665.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2022-05-12
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2022-03-31 was -$665.00K.
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2021-12-31 was -$1.12M.
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2021-09-30 was -$80.00K.
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2021-06-30 was $8.75M.
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2021 was $6.53M.
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2020 was -$1.90M.
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2019 was $0.00.
- SUPERNUS PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 3 month as first filed | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | -$665.00K 10-Q · filed 2022-05-12 | -$1.78M derived: sum of 2 quarters · filed 2022-05-12 | -$1.86M derived: sum of 3 quarters · filed 2022-05-12 | $6.88M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | -$1.20M derived: sum of 2 quarters · filed 2022-04-13 | $7.55M derived: sum of 3 quarters · filed 2022-04-13 | $6.53M 10-K · filed 2022-04-13 | |
| 2021-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $8.67M derived: sum of 2 quarters · filed 2021-11-05 | $7.65M 10-Q · filed 2021-11-05 | $5.95M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-06-30 | $8.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $7.73M 10-Q · filed 2021-08-06 | $6.03M derived: sum of 3 quarters · filed 2022-05-12 | $5.83M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-03-31 | -$1.02M 10-Q · filed 2022-05-12 | -$2.72M derived: sum of 2 quarters · filed 2022-05-12 | -$2.92M derived: sum of 3 quarters · filed 2022-05-12 | -$2.92M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | -$1.90M derived: sum of 2 quarters · filed 2022-04-13 | -$1.90M derived: sum of 3 quarters · filed 2022-04-13 | -$1.90M 10-K · filed 2022-04-13 | |
| 2020-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$200.00K derived: sum of 2 quarters · filed 2021-11-05 | -$200.00K 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-04-13 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-08 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $0.00 derived: sum of 2 quarters · filed 2020-02-28 | $22.00K derived: sum of 3 quarters · filed 2020-02-28 | $76.00K 10-K · filed 2020-02-28 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $22.00K derived: sum of 2 quarters · filed 2018-11-09 | $76.00K 10-Q · filed 2018-11-09 | $175.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $76.00K 10-Q · filed 2018-08-09 | $175.00K derived: sum of 3 quarters · filed 2019-03-01 | $300.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $54.00K 10-Q · filed 2018-05-10 | $153.00K derived: sum of 2 quarters · filed 2019-03-01 | $278.00K derived: sum of 3 quarters · filed 2019-03-01 | $401.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $224.00K derived: sum of 2 quarters · filed 2019-03-01 | $347.00K derived: sum of 3 quarters · filed 2019-03-01 | $448.00K 10-K · filed 2019-03-01 | |
| 2016-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $248.00K derived: sum of 2 quarters · filed 2017-11-09 | $349.00K 10-Q · filed 2017-11-09 | $476.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $224.00K 10-Q · filed 2017-08-03 | $351.00K derived: sum of 3 quarters · filed 2018-03-01 | $465.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | $101.00K 10-Q · filed 2017-05-09 | $228.00K derived: sum of 2 quarters · filed 2018-03-01 | $342.00K derived: sum of 3 quarters · filed 2018-03-01 | $343.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $127.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $241.00K derived: sum of 2 quarters · filed 2018-03-01 | $242.00K derived: sum of 3 quarters · filed 2018-03-01 | $193.00K 10-K · filed 2018-03-01 | |
| 2015-09-30 | $114.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-01-20 | $115.00K derived: sum of 2 quarters · filed 2017-01-23 | $66.00K 10-Q/A · filed 2017-01-20 | $760.00K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | $1.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-01-23 | -$48.00K 10-Q/A · filed 2017-01-23 | $646.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.41M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | -$49.00K 10-Q/A · filed 2017-01-20 | $645.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.41M derived: sum of 3 quarters · filed 2017-03-16 | $2.08M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-12-31 | $694.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $1.45M derived: sum of 2 quarters · filed 2017-03-16 | $2.13M derived: sum of 3 quarters · filed 2017-03-16 | $2.81M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $760.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | $1.44M derived: sum of 2 quarters · filed 2017-01-20 | $2.12M 10-Q/A · filed 2017-01-20 | $1.45M derived: sum of 4 quarters · filed 2017-01-20 | |
| 2014-06-30 | $678.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.35M 10-Q · filed 2015-08-07 | $693.00K derived: sum of 3 quarters · filed 2017-01-20 | -$3.46M derived: sum of 4 quarters · filed 2017-01-20 | |
| 2014-03-31 | $677.00K 10-Q · filed 2015-05-06 | $15.00K derived: sum of 2 quarters · filed 2017-01-20 | -$4.14M derived: sum of 3 quarters · filed 2017-01-20 | -$12.76M derived: sum of 4 quarters · filed 2017-01-20 | |
| 2013-12-31 | -$662.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | -$4.81M derived: sum of 2 quarters · filed 2017-01-20 | -$13.43M derived: sum of 3 quarters · filed 2017-01-20 | -$13.35M 10-K/A · filed 2017-01-20 | |
| 2013-09-30 | -$4.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$12.77M derived: sum of 2 quarters · filed 2014-11-12 | -$12.69M 10-Q · filed 2014-11-12 | -$12.64M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | -$8.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$8.54M 10-Q · filed 2014-08-12 | -$8.48M derived: sum of 3 quarters · filed 2015-03-12 | -$8.78M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $80.00K 10-Q · filed 2014-05-13 | $79.00K 10-Q · filed 2013-05-15 | $136.00K derived: sum of 2 quarters · filed 2015-03-12 | -$158.00K derived: sum of 3 quarters · filed 2015-03-12 | -$302.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$238.00K derived: sum of 2 quarters · filed 2015-03-12 | -$382.00K derived: sum of 3 quarters · filed 2015-03-12 | -$710.00K 10-K · filed 2015-03-12 | |
| 2012-09-30 | -$294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$438.00K derived: sum of 2 quarters · filed 2013-11-13 | -$766.00K 10-Q · filed 2013-11-13 | -$861.00K derived: sum of 4 quarters · filed 2014-03-21 | |
| 2012-06-30 | -$144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$472.00K 10-Q · filed 2013-08-14 | -$567.00K derived: sum of 3 quarters · filed 2014-03-21 | -$646.00K derived: sum of 4 quarters · filed 2014-03-21 | |
| 2012-03-31 | -$328.00K 10-Q · filed 2013-05-15 | -$423.00K derived: sum of 2 quarters · filed 2014-03-21 | -$502.00K derived: sum of 3 quarters · filed 2014-03-21 | -$440.00K derived: sum of 4 quarters · filed 2014-03-21 | |
| 2011-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$174.00K derived: sum of 2 quarters · filed 2014-03-21 | -$112.00K derived: sum of 3 quarters · filed 2014-03-21 | -$85.00K 10-K · filed 2014-03-21 | |
| 2011-09-30 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$17.00K derived: sum of 2 quarters · filed 2012-11-02 | $10.00K 10-Q · filed 2012-11-02 | ||
| 2011-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $89.00K 10-Q · filed 2012-08-13 | |||
| 2011-03-31 | $27.00K 10-Q · filed 2012-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |